M E15 (Enalapril 2.5 mg)
Pill imprint M E15 has been identified as Enalapril maleate 2.5 mg.
Enalapril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; hypertensive emergency; left ventricular dysfunction (and more), and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy. Enalapril 2.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- M E15
- 2.5 mg
- 6.00 mm
- Prescription only
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose anhydrous
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|51079-0950||UDL Laboratories Inc|
|35356-0541||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about enalapril
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.